HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,894 | +3.2% | 32,301 | -2.0% | 0.02% | +8.7% |
Q2 2023 | $2,805 | +0.5% | 32,944 | -2.4% | 0.02% | -4.2% |
Q1 2023 | $2,792 | -0.9% | 33,737 | -5.8% | 0.02% | -4.0% |
Q4 2022 | $2,816 | -99.9% | 35,801 | +0.6% | 0.02% | 0.0% |
Q3 2022 | $2,634,000 | +16.6% | 35,575 | +2.6% | 0.02% | +19.0% |
Q2 2022 | $2,259,000 | +5.3% | 34,659 | +2.1% | 0.02% | +23.5% |
Q1 2022 | $2,146,000 | -43.1% | 33,943 | -52.3% | 0.02% | +21.4% |
Q4 2021 | $3,770,000 | +51.2% | 71,092 | +101.2% | 0.01% | -33.3% |
Q3 2021 | $2,494,000 | -4.3% | 35,327 | -9.7% | 0.02% | 0.0% |
Q2 2021 | $2,607,000 | +145.0% | 39,120 | +308.0% | 0.02% | -47.5% |
Q1 2021 | $1,064,000 | -12.6% | 9,589 | -6.5% | 0.04% | -13.0% |
Q4 2020 | $1,218,000 | +36.5% | 10,259 | +0.4% | 0.05% | +17.9% |
Q3 2020 | $892,000 | -5.2% | 10,223 | -2.7% | 0.04% | -11.4% |
Q2 2020 | $941,000 | -1.8% | 10,506 | +9.2% | 0.04% | +91.3% |
Q1 2020 | $958,000 | -17.8% | 9,617 | -5.2% | 0.02% | +9.5% |
Q4 2019 | $1,166,000 | -3.0% | 10,147 | +6.5% | 0.02% | -16.0% |
Q3 2019 | $1,202,000 | +3.3% | 9,528 | -1.5% | 0.02% | -7.4% |
Q2 2019 | $1,164,000 | +60.8% | 9,674 | +16.8% | 0.03% | +50.0% |
Q1 2019 | $724,000 | -10.8% | 8,281 | +2.0% | 0.02% | -21.7% |
Q4 2018 | $812,000 | +98.0% | 8,117 | +126.6% | 0.02% | +130.0% |
Q3 2018 | $410,000 | -47.8% | 3,582 | -59.1% | 0.01% | -47.4% |
Q2 2018 | $785,000 | +39.2% | 8,757 | +13.6% | 0.02% | +26.7% |
Q1 2018 | $564,000 | +25.3% | 7,711 | -0.5% | 0.02% | +25.0% |
Q4 2017 | $450,000 | +39.8% | 7,752 | +8.1% | 0.01% | +20.0% |
Q3 2017 | $322,000 | +11.4% | 7,172 | -2.0% | 0.01% | +11.1% |
Q2 2017 | $289,000 | +2.8% | 7,322 | +5.7% | 0.01% | -35.7% |
Q1 2017 | $281,000 | +1.1% | 6,930 | +0.1% | 0.01% | +7.7% |
Q4 2016 | $278,000 | +25.8% | 6,923 | +13.5% | 0.01% | 0.0% |
Q3 2016 | $221,000 | +0.9% | 6,101 | +0.2% | 0.01% | 0.0% |
Q2 2016 | $219,000 | -0.9% | 6,088 | +14.0% | 0.01% | -40.9% |
Q2 2015 | $221,000 | -0.9% | 5,341 | +0.9% | 0.02% | -42.1% |
Q4 2013 | $223,000 | – | 5,295 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |